Samar J. Kamdar - 03 Apr 2023 Form 4 Insider Report for biote Corp. (BTMD)

Reporting relationship: Chief Financial Officer
Issuer ticker: BTMD
Reported as of: 03 Apr 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 05 Apr 2023, 21:34:13 UTC
Prior SEC filing: 10 Jan 2023
Source filing: View source filing
Reporting owner signature: /s/ Marybeth Conlon, as Attorney-in-Fact for Samar J. Kamdar

Key filing fact

Samar J. Kamdar filed Form 4 for biote Corp. (BTMD) on 05 Apr 2023.

Key facts

This page summarizes Samar J. Kamdar's Form 4 filing for biote Corp. (BTMD).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 05 Apr 2023, 21:34.

Change

Previous filing in this sequence was filed on 10 Jan 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BTMD transaction Derivative

Employee Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +45,000
Change %: +18%
Price: $0.000000
Shares after: 295,000
Date: 03 Apr 2023
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 45,000
Exercise price: $5.80
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

25% of the shares subject to the option shall vest on April 3, 2024, and the remaining shares subject to the option shall vest in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.